Ehp Funds Inc. Silence Therapeutics PLC Transaction History
Ehp Funds Inc.
- $71.6 Million
- Q3 2025
A detailed history of Ehp Funds Inc. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Ehp Funds Inc. holds 10,673 shares of SLN stock, worth $73,323. This represents 0.08% of its overall portfolio holdings.
Number of Shares
10,673Holding current value
$73,323% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding SLN
# of Institutions
54Shares Held
20.6MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$20.8 Million1.76% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$20 Million0.59% of portfolio
-
Redmile Group, LLC San Francisco, CA2.16MShares$14.9 Million1.24% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.84MShares$12.7 Million0.69% of portfolio
-
Morgan Stanley New York, NY1.21MShares$8.3 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $247M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...